Click a link below to view the mailing archive as if it had been sent to you.
| 2025-08-30 00:15 | | J&J removes some Abiomed heart pump controllers from market |
| 2025-08-29 12:15 | | J&J ends rheumatoid arthritis program after disappointing mid-stage data and more... |
| 2025-08-29 00:15 | | Months after layoffs, AbbVie-partnered protein degrader specialist Plexium raises $60M and more... |
| 2025-08-28 12:15 | | Novo strikes RNA drug deal with startup Replicate and more... |
| 2025-08-28 00:15 | | Eli Lilly temporarily halts UK shipments of weight-loss drug Mounjaro and more... |
| 2025-08-27 12:15 | | Pharma spent more than $48B in China in H1, eclipsing total 2024 haul and more... |
| 2025-08-27 00:15 | | Drugmakers Hail Early Wins in AI-Driven Transformation of Manufacturing and more... |
| 2025-08-26 12:15 | | Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval and more... |
| 2025-08-26 00:15 | | MannKind grabs scPharmaceuticals and its heart failure infuser Furoscix in $360M deal and more... |
| 2025-08-25 12:15 | | AbbVie tunes in to Gilgamesh's story, inking $1.2B deal for psychedelic program and more... |
| 2025-08-22 12:15 | | Oral obesity candidates disappoint with Novo emerging as leader of the pack and more... |
| 2025-08-22 00:15 | | Trump locks in 15% pharmaceutical tariff rate for EU, while generic drugs get a pass and more... |
| 2025-08-21 12:15 | | Gilead unit Kite Pharma to acquire cell therapy developer Interius for $350 million and more... |
| 2025-08-21 00:15 | | CVS Health won’t cover Gilead’s new HIV prevention drug Yeztugo and more... |
| 2025-08-20 12:15 | | Novo Nordisk, under new CEO Doustdar, freezes hiring in non-critical business areas and more... |
| 2025-08-20 00:15 | | Several US pharma giants stage Q2 sales turnaround after subpar results earlier in year and more... |
| 2025-08-19 12:15 | | Amgen's ChemoCentryx prevails in investor lawsuit centered on autoimmune drug Tavneos and more... |
| 2025-08-19 00:15 | | FDA extends review of REGENXBIO’s Hunter syndrome therapy and more... |
| 2025-08-18 12:15 | | Biopharma layoffs rise as drugmakers tighten belts and reorganize and more... |
| 2025-08-18 00:15 | | Novo Nordisk wins FDA label expansion for Wegovy against liver disease MASH and more... |
| 2025-08-16 00:15 | | Pfizer sickle cell drug fails trial |
| 2025-08-15 12:15 | | Amgen skirts $50M payout in Blincyto patent litigation tiff with Lindis and more... |
| 2025-08-15 00:15 | | Enhertu, Keytruda promos put AZ, Merck at the front of the oncology HCP marketing pack: report and more... |
| 2025-08-14 12:15 | | Apple’s blood oxygen monitoring returns to its latest Apple Watches and more... |
| 2025-08-14 00:15 | | CSL's Venofer finally faces generic competition as FDA clears copycats from Viatris, Sandoz and Amphastar and more... |
| 2025-08-13 12:15 | | Merck begins 8% workforce purge, laying off 58 at its New Jersey HQ and more... |
| 2025-08-13 11:16 | | Merck begins 8% workforce purge, laying off 58 at its New Jersey HQ and more... |
| 2025-08-12 12:17 | | Obesity leaders dig manufacturing moats to defend injectable GLP-1 empires and more... |
| 2025-08-11 21:52 | | Semaglutide improves clinical markers but raises overall spending: Study and more... |
| 2025-08-11 11:42 | | Novartis drug acquired in Morphosys deal succeeds against tough-to-treat autoimmune disease and more... |
| 2025-08-10 22:37 | | Where Will Walgreens Be in 1 Year? and more... |
| 2025-08-08 12:05 | | Could Basel be the next Boston? How the Swiss biotech hub is quietly raising its game and more... |
| 2025-08-07 22:04 | | Trump, pharma industry discuss boosting medicine spending abroad to cut US prices, sources say and more... |
| 2025-08-07 11:53 | | Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar and more... |
| 2025-08-06 23:04 | | Avidity Biosciences stock soars on Novartis takeover approach report and more... |
| 2025-08-06 12:12 | | Novo Nordisk, maker of Ozempic and Wegovy, warns of job cuts and more... |
| 2025-08-05 12:00 | | Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results and more... |
| 2025-08-04 23:38 | | Lilly confirms plan to sell NJ plant amid larger US production ramp-up and more... |
| 2025-08-04 11:58 | | Moderna's Bancel nay on M&A, yay on R&D partnerships and more... |
| 2025-08-01 13:06 | | Regulatory roadblocks blemish Regeneron's otherwise strong Q2 and more... |
